Canagliflozin enhances senescent cell clearance, improving aging-related conditions

FHS
June 3, 2024
9:13 am

Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.

New SCLC biomarkers enable advances in precision medicine approaches

A new research paper was published in Oncotarget’s Volume 15 on October 11, 2024, entitled “Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67:

November 7, 2024

New guidelines for imaging estrogen receptor in breast cancer patients using FES PET

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for

January 6, 2024

Coherus acquires immuno-oncology company Surface

Surface Oncology focuses on the development of immunotherapies that act on the microenvironment of the tumour. Credit: CI Photos/Shutterstock.com. Coherus BioSciences has concluded the acquisition of

September 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.